In patients with both obesity and type 2 diabetes, these two common metabolic disorders share some pathophysiology, which was associated with decreased fasting plasma levels of FGF19 [4]. The gene discussed is FGF19; the disease is obesity due to melanocortin 4 receptor deficiency.